• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of the left atrial appendage closure in preventing thromboembolism in atrial fibrillation: what is the importance for chronic kidney disease patients?

作者信息

Genovesi Simonetta, Bianchi Stefano, Basile Carlo

机构信息

School of Medicine and Surgery, University of Milano-Bicocca, Nephrology Clinic, Via Cadore 48, 20900, Monza, Italy.

Istituto Auxologico Italiano, IRCCS, Milan, Italy.

出版信息

J Nephrol. 2024 Jun;37(5):1197-1200. doi: 10.1007/s40620-024-01944-5. Epub 2024 Apr 24.

DOI:10.1007/s40620-024-01944-5
PMID:38656567
Abstract
摘要

相似文献

1
Role of the left atrial appendage closure in preventing thromboembolism in atrial fibrillation: what is the importance for chronic kidney disease patients?左心耳封堵在预防心房颤动血栓栓塞中的作用：对慢性肾脏病患者有何重要性？
J Nephrol. 2024 Jun;37(5):1197-1200. doi: 10.1007/s40620-024-01944-5. Epub 2024 Apr 24.
2
Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation.左心耳封堵：血友病合并心房颤动患者血栓栓塞风险的平衡管理
J Thromb Thrombolysis. 2020 Oct;50(3):668-673. doi: 10.1007/s11239-020-02097-5.
3
Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention?老年心房颤动合并慢性肾脏病患者管理中的未决问题：我们是否准备好将左心耳封堵术（LAAO）作为预防血栓栓塞风险的一线治疗方法？
Cardiovasc Drugs Ther. 2024 Jun;38(3):401-403. doi: 10.1007/s10557-024-07554-4. Epub 2024 Jan 26.
4
[Percutaneous closure of the left atrial appendage: Eliminate the thromboembolic risk of atrial fibrillation?].
J Med Vasc. 2018 Feb;43(1):1-3. doi: 10.1016/j.jdmv.2017.12.001. Epub 2017 Dec 27.
5
Zero-Contrast Left Atrial Appendage Closure in Patients With Chronic Kidney Disease.慢性肾脏病患者的无对比剂左心耳封堵术。
Circ J. 2023 Dec 25;88(1):170-174. doi: 10.1253/circj.CJ-23-0553. Epub 2023 Nov 30.
6
Percutaneous Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation and End-Stage Renal Disease on Hemodialysis: A Case Series.经皮左心耳封堵术治疗非瓣膜性心房颤动合并终末期肾病血液透析患者：病例系列研究。
Medicina (Kaunas). 2024 Jan 29;60(2):231. doi: 10.3390/medicina60020231.
7
[Early to Long-term Results of Left Atrial Appendage Closure Using Clip Device in Patients with Atrial Fibrillation].[心房颤动患者使用夹子装置进行左心耳封堵的早期至长期结果]
Kyobu Geka. 2024 Jan;77(1):35-37.
8
The cessation of oral anticoagulation following left atrial appendage surgery.左心耳手术后口服抗凝治疗的停止。
Future Cardiol. 2018 Sep;14(5):407-415. doi: 10.2217/fca-2018-0010. Epub 2018 Sep 20.
9
Left atrial appendage closure in a patient with atrial fibrillation after mechanical mitral valve replacement and cardio-embolic stroke despite effective oral anticoagulant therapy: a case report.二尖瓣机械瓣置换术后房颤患者在接受有效的口服抗凝治疗后仍发生心源性栓塞性卒中，行左心耳封堵术：一例报告
Clin Res Cardiol. 2014 Jul;103(7):587-9. doi: 10.1007/s00392-014-0704-4. Epub 2014 Apr 1.
10
[Monocentric experience of left atrial appendage occlusion among patients with advanced chronic kidney disease and non-valvular atrial fibrillation].
G Ital Nefrol. 2020 Feb 12;37(1):2020-vol1.

本文引用的文献

1
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心脏节律协会/心律学会/亚太心脏节律学会/拉丁美洲心脏节律学会专家共识声明：导管和手术消融治疗心房颤动。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae043.
2
Effect of atherosclerosis on the relationship between atrial fibrillation and ischemic stroke incidence among patients on hemodialysis.动脉粥样硬化对血液透析患者心房颤动与缺血性卒中发生率关系的影响。
Sci Rep. 2024 Jan 15;14(1):1330. doi: 10.1038/s41598-024-51439-3.
3
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study.
左心耳封堵术在房颤透析患者中的长期安全性和有效性：一项多中心、前瞻性、开放标签、观察性研究。
Clin Kidney J. 2023 Sep 4;16(12):2683-2692. doi: 10.1093/ckj/sfad221. eCollection 2023 Dec.
4
Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation.慢性肾脏病患者行左心耳封堵术治疗心房颤动的疗效及安全性。
PLoS One. 2023 Oct 26;18(10):e0287928. doi: 10.1371/journal.pone.0287928. eCollection 2023.
5
Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis.直接口服抗凝剂与维生素 K 拮抗剂在接受血液透析的心房颤动和终末期肾病患者中的疗效和安全性：系统评价和荟萃分析。
Eur J Intern Med. 2024 Jan;119:45-52. doi: 10.1016/j.ejim.2023.08.020. Epub 2023 Aug 28.
6
Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.直接口服抗凝剂与华法林在肾功能谱中的比较：来自 COMBINE AF 的患者水平网络荟萃分析。
Circulation. 2023 Jun 6;147(23):1748-1757. doi: 10.1161/CIRCULATIONAHA.122.062752. Epub 2023 Apr 12.
7
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.左心耳封堵术与非华法林口服抗凝药治疗心房颤动的 4 年结局。
J Am Coll Cardiol. 2022 Jan 4;79(1):1-14. doi: 10.1016/j.jacc.2021.10.023. Epub 2021 Nov 5.
8
Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis.华法林在房颤患者中的应用与终末期肾病患者结局的相关性：系统评价和荟萃分析。
JAMA Netw Open. 2020 Apr 1;3(4):e202175. doi: 10.1001/jamanetworkopen.2020.2175.
9
5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.左心耳封堵术后 5 年的结果：来自 PREVAIL 和 PROTECT AF 试验。
J Am Coll Cardiol. 2017 Dec 19;70(24):2964-2975. doi: 10.1016/j.jacc.2017.10.021. Epub 2017 Nov 4.